Literature DB >> 12776179

Targeting mortalin using conventional and RNA-helicase-coupled hammerhead ribozymes.

Renu Wadhwa1, Hiroshi Ando, Hiroaki Kawasaki, Kazunari Taira, Sunil C Kaul.   

Abstract

Mortalin, also known as mot2/mthsp70/GRP75/PBP74, is a member of the heat-shock protein 70 family that is heat-uninducible. It is differentially distributed in cells that have normal and immortal phenotypes, has been localized to various subcellular sites, and has several binding partners and functions. Here, we describe the construction and use of mortalin-specific conventional and hybrid ribozymes to elucidate its crucial role in cell proliferation. Whereas conventional hammerhead ribozymes did not cause any repression of endogenous mortalin expression, RNA-helicase-linked hybrid ribozymes successfully suppressed the expression of mortalin, which resulted in the growth arrest of transformed human cells. We show that, first, RNA helicase-coupled hybrid ribozymes that have a linked unwinding activity can be used to target genes for which conventional hammerhead ribozymes are ineffective; second, the targeting of mortalin by RNA-helicase-coupled hybrid ribozymes causes growth suppression of transformed human cells and could be used as a treatment for cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12776179      PMCID: PMC1319200          DOI: 10.1038/sj.embor.embor855

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  31 in total

1.  Structural biology. The ribosome is a ribozyme.

Authors:  T R Cech
Journal:  Science       Date:  2000-08-11       Impact factor: 47.728

Review 2.  Boundaries for an RNA world.

Authors:  M Yarus
Journal:  Curr Opin Chem Biol       Date:  1999-06       Impact factor: 8.822

3.  Inactivation of p53 and life span extension of human diploid fibroblasts by mot-2.

Authors:  S C Kaula; R R Reddelb; T Sugiharac; Y Mitsuia; R Wadhwac
Journal:  FEBS Lett       Date:  2000-06-02       Impact factor: 4.124

4.  Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III.

Authors:  S Koseki; T Tanabe; K Tani; S Asano; T Shioda; Y Nagai; T Shimada; J Ohkawa; K Taira
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

5.  Selection of the best target site for ribozyme-mediated cleavage within a fusion gene for adenovirus E1A-associated 300 kDa protein (p300) and luciferase.

Authors:  H Kawasaki; J Ohkawa; N Tanishige; K Yoshinari; T Murata; K K Yokoyama; K Taira
Journal:  Nucleic Acids Res       Date:  1996-08-01       Impact factor: 16.971

6.  Ribozymes. Hammerhead nailed down.

Authors:  T R Cech; O C Uhlenbeck
Journal:  Nature       Date:  1994-11-03       Impact factor: 49.962

7.  Protein expression profiles in human breast ductal carcinoma and histologically normal tissue.

Authors:  L Bini; B Magi; B Marzocchi; F Arcuri; S Tripodi; M Cintorino; J C Sanchez; S Frutiger; G Hughes; V Pallini; D F Hochstrasser; P Tosi
Journal:  Electrophoresis       Date:  1997-12       Impact factor: 3.535

8.  Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member.

Authors:  R Wadhwa; S Takano; M Robert; A Yoshida; H Nomura; R R Reddel; Y Mitsui; S C Kaul
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

9.  Peptide bond formation by in vitro selected ribozymes.

Authors:  B Zhang; T R Cech
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

10.  Malignant transformation of NIH3T3 cells by overexpression of mot-2 protein.

Authors:  S C Kaul; E L Duncan; A Englezou; S Takano; R R Reddel; Y Mitsui; R Wadhwa
Journal:  Oncogene       Date:  1998-08-20       Impact factor: 9.867

View more
  11 in total

1.  Identification and characterization of molecular interactions between mortalin/mtHsp70 and HSP60.

Authors:  Renu Wadhwa; Syuichi Takano; Kamaljit Kaur; Satoshi Aida; Tomoko Yaguchi; Zeenia Kaul; Takashi Hirano; Kazunari Taira; Sunil C Kaul
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

2.  Molecular interactions of Bcl-2 and Bcl-xL with mortalin: identification and functional characterization.

Authors:  Nishant Saxena; Shashank P Katiyar; Ye Liu; Abhinav Grover; Ran Gao; Durai Sundar; Sunil C Kaul; Renu Wadhwa
Journal:  Biosci Rep       Date:  2013-10-16       Impact factor: 3.840

3.  HSP70s: From Tumor Transformation to Cancer Therapy.

Authors:  Chih-Wen Shu; Chun-Ming Huang
Journal:  Clin Med Oncol       Date:  2008-04-24

4.  Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cells.

Authors:  Nupur Nigam; Abhinav Grover; Sukriti Goyal; Shashank P Katiyar; Priyanshu Bhargava; Pi-Chao Wang; Durai Sundar; Sunil C Kaul; Renu Wadhwa
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

5.  Hep88 mAb-initiated paraptosis-like PCD pathway in hepatocellular carcinoma cell line through the binding of mortalin (HSPA9) and alpha-enolase.

Authors:  Panadda Rojpibulstit; Suthathip Kittisenachai; Songchan Puthong; Sirikul Manochantr; Pornpen Gamnarai; Sarawut Jitrapakdee; Sittiruk Roytrakul
Journal:  Cancer Cell Int       Date:  2014-07-22       Impact factor: 5.722

6.  SMR peptide antagonizes mortalin promoted release of extracellular vesicles and affects mortalin protection from complement-dependent cytotoxicity in breast cancer cells and leukemia cells.

Authors:  Ming-Bo Huang; Jennifer Y Wu; James Lillard; Vincent C Bond
Journal:  Oncotarget       Date:  2019-09-10

7.  Colocalisation of CD9 and mortalin in CD9-induced mitotic catastrophe in human prostate cancer cells.

Authors:  V Zvereff; J-C Wang; K Shun; J Lacoste; M Chevrette
Journal:  Br J Cancer       Date:  2007-09-11       Impact factor: 7.640

8.  Effective suppression of Dengue fever virus in mosquito cell cultures using retroviral transduction of hammerhead ribozymes targeting the viral genome.

Authors:  Pruksa Nawtaisong; James Keith; Tresa Fraser; Velmurugan Balaraman; Andrey Kolokoltsov; Robert A Davey; Stephen Higgs; Ahmed Mohammed; Yupha Rongsriyam; Narumon Komalamisra; Malcolm J Fraser
Journal:  Virol J       Date:  2009-06-04       Impact factor: 4.099

9.  Mortalin, apoptosis, and neurodegeneration.

Authors:  Carolina Londono; Cristina Osorio; Vivian Gama; Oscar Alzate
Journal:  Biomolecules       Date:  2012-03-01

10.  The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast.

Authors:  Haidan Jin; Meiying Ji; Liyan Chen; Qixiang Liu; Shuanlong Che; Ming Xu; Zhenhua Lin
Journal:  J Exp Clin Cancer Res       Date:  2016-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.